AMRN Q2 2017 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$335M

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$45M+36.6% YoY

Gross Profit

$34M74.8% margin

Operating Income

-$11M-25.2% margin

Net Income

-$14M-30.1% margin

EPS (Diluted)

$-1.01

QoQ Revenue Growth

+30.6%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$170M

Total Liabilities

$209M

Stockholders' Equity

-$39M

Cash & Equivalents

$85M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$45M	$33M	+36.6%
Gross Profit	$34M	$24M	+39.5%
Operating Income	-$11M	-$14M	+20.8%
Net Income	-$14M	-$13M	-2.1%